Replies to post #454869 on Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

Exactly what I’ve been saying. Missling has little (or nothing) to do with whether they get approval or not and, thus, whether the company succeeds. The trial results are what they are and experts are preparing the submissions. So will they design and conduct additional trials.

[sumbuysumsell]

Since that time decades ago they've promoted Phase 3 Trials against all sorts of different diseases, all with the very same drug. In short, they have a cure in search of it's disease. You really don't want a company that operates as they do.

With a history of failing to release trial results and bouncing to the next indication one could easily think you are talking about Anavex with this statement. According to their own pipeline chart (while not entirely correct) currently lists 2-73 with completed or planned P3 trials for 7 indications.
https://www.anavex.com/therapeutic-candidates

[baltimorebullet]

Well said.

The age old question is "Would you buy the stock now?":
140 million in cash, no debt, EMA encouraging our advances, FDA accelerated approval application coming in a known and timely manner, phase 2 trial in a second drug started, at the minimum an adult Rett approval likely, increasing institutional ownership...
Yes I would buy and did on Friday.
Things have never looked brighter.